K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC.
Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April.
Sentinel—Investment company expecting NEX admission/introduction on 24 March. £ ....
23 Mar 2017
Small Cap Breakfast
Produce Investments (PIL:LON), 0 | Gfinity PLC (GFIN:LON), 0.1 | Solid State plc (SOLI:LON), 1,350 | Craneware plc (CRW:LON), 2,250 | Science In Sport Plc (SIS:LON), 15.2 | Vela Technologies plc (VELA:LON), 0 | Venture Life Group Plc (VLG:LON), 36.0 | Progility (PGY:LON), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Breakfast
Produce Investments (PIL:LON), 0 | Gfinity PLC (GFIN:LON), 0.1 | Solid State plc (SOLI:LON), 1,350 | Craneware plc (CRW:LON), 2,250 | Science In Sport Plc (SIS:LON), 15.2 | Vela Technologies plc (VELA:LON), 0 | Venture Life Group Plc (VLG:LON), 36.0 | Progility (PGY:LON), 0
- Published:
23 Mar 2017 -
Author:
Derren Nathan - Pages:
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC.
Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April.
Sentinel—Investment company expecting NEX admission/introduction on 24 March. £ ....